Highlights
NYSE: RCUS       Arcus Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
20.14   -0.19 (0.93%)  19.72 - 20.57  452,100

Overview

 
Avg Volume (4 weeks):426,875
4 Weeks Range:16.69 - 21.15
4 Weeks Price Volatility (%):
77.35%
52 Weeks Range:7.19 - 37.41
52 Weeks Price Volatility (%):
42.85%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. The company focuses on an ATP-adenosine pathway which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. The pipeline products of the company include dual and selective A2R antagonists, small-molecule and antibody programs which target solid tumors. The company operates through the single segment being the business of developing and commercializing immunotherapies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22